Clinical Trials List
Protocol NumberCABL001L12101
Not yet recruiting
2026-02-23 - 2032-12-31
Phase I/II
Recruiting1
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- SHIANN-TANG JOU Division of Pediatrics
- YUNG-LI YANG Division of Pediatrics
- 張修豪 Division of Pediatrics
- HSIN-AN HOU Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Chien-Chin Lin Division of Others -
- Chieh-Lung Cheng Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- 周書緯 Division of Pediatrics
- 杜佳叡 Division of Pediatrics
- - - Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- 林明恩 Division of Hematology & Oncology
- YAO CHI-YUAN Division of Hematology & Oncology
- 李思慧 Division of General Internal Medicine
- 楊鎰聰 Division of Hematology & Oncology
- 李婉瑄 Division of Hematology & Oncology
- 鄭喬予 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
40 participants
